|
Apr 2
|
European Equities Close Lower in Wednesday Trading; Brookfield in Talks Again to Acquire Grifols
|
|
Apr 2
|
Spanish pharma company Grifols' shares up on Brookfield talk
|
|
Mar 10
|
High Growth Tech Stocks in Europe for March 2025
|
|
Feb 27
|
Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?
|
|
Feb 27
|
Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...
|
|
Jan 2
|
Exploring Three High Growth Tech Stocks For Future Potential
|
|
Oct 3
|
High Growth Tech Stocks To Watch In October 2024
|
|
Oct 3
|
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
|
|
Sep 30
|
Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say
|
|
Sep 25
|
Sector Update: Health Care Stocks Fall Late Afternoon
|
|
Sep 19
|
Grifols Investor Group With 7.7% Holding Seeks Seat on Board
|
|
Sep 10
|
Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’
|
|
Sep 3
|
Grifols Postpones Capital Markets Day Amid Potential Takeover
|
|
Aug 29
|
Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid
|
|
Jul 29
|
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
|
|
May 9
|
Short Seller Gains on Grifols Bet That Tripped Elliott Spinout
|
|
Apr 19
|
Grifols 2023 Annual Report on Form 20-F filed with the SEC
|
|
Apr 18
|
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
|
|
Apr 14
|
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
|
|
Apr 10
|
Grifols Plans First Bond Sale Since Short Seller Attack
|